A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: not linked (714), not related (682), distinct (21), dissimilar (1), disparate (5), irrelevant (6)

ImatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • A
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

DasatinibAccelerated

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (accelerated phase) Funding may be required for specific indications Regime
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibAccelerated.pdf

Press release: Leading doctor warns use of blood test to diagnose heart attacks is 'flawed'

Description
A leading cardiac specialist has said some patients who suffer suspected heart attacks could be receiving inappropriate investigations and unnecessary treatment
Url
/AboutTheTrust/Newsandpublications/Latestnews/2019/March/Press-release-Leading-doctor-warns-use-of-blood-test-to-diagnose-heart-attacks-is-flawed.aspx

HSCTAlemtuzumabBusulphan-08-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (8 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITIONING This regimen will only
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-8-Fludarabine-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabBusulphan-10-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (10 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITIONING This regimen will only
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-10-Fludarabine-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabCyclophosphamideTBI_VUD_Methotrexate_GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION (TBI)METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) Conditioning This regimen will
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabCyclophosphamideTBI-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabFludarabineMelphalan-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-FLUDARABINE-MELPHALAN-METHOTREXATE (GVHD) Volunteer Unrelated Donor (VUD) Conditioning This regimen will only be available
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabFludarabineMelphalan-VUD-Methotrexate-GvHD.pdf

HSCTAlemtuzumabBusulphan-12-Fludarabine-VUD-Methotrexate-GvHD

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT ALEMTUZUMAB-BUSULFAN (12 doses)-FLUDARABINE-METHOTREXATE (GvHD) Volunteer Unrelated Donor (VUD) CONDITIONING This regimen will only
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTAlemtuzumabBusulphan-12-Fludarabine-VUD-Methotrexate-GvHD.pdf

Press release: Doctors develop app to predict risk of asthma in children

Description
Researchers in Southampton and the US have created an app that can predict a child's risk of asthma through six simple
Url
/AboutTheTrust/Newsandpublications/Latestnews/2018/December/Press-release-Doctors-develop-app-to-predict-risk-of-asthma-in-children.aspx

Press release: Children's charity launches first hospital-based pre-school

Description
A charity set up by a family in memory of their late daughter has launched the first hospital-based pre-school
Url
/AboutTheTrust/Newsandpublications/Latestnews/2018/May-2018/Press-release-Childrens-charity-launches-first-hospital-based-pre-school.aspx
1 to 10 of 28
Previous 1 2 3 Next